Codeine-Guaifenesin
- Product NDC
- 68071-5173
- 11-digit product format
- 680715173
- Labeler code
- 68071
- Product ID
- 68071-5173_1b56a7bc-e859-d8c7-e063-6294a90a5ee1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Codeine Phosphate and Guaifenesin
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2014-04-01
- Substance
- CODEINE PHOSPHATE; GUAIFENESIN
- Active strength
- 10; 100 mg/5mL; mg/5mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Full Opioid Agonists [MoA], Increased Respiratory Secretions [PE], Opioid Agonist [EPC]
- DEA schedule
- CV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-5173-4 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-5173-4 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-5173-4 | 1332a3947898… | d4bfe170f9cd… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Codeine-Guaifenesin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CODEINE PHOSPHATE | 10 mg/5mL |
| GUAIFENESIN | 100 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| GSL05Y1MN6 | Internal UNII lookup |
| 495W7451VQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995868 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9e691264-d48a-6b48-e053-2995a90a9352 | Available on FDA.report |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-5173-4 | 2024-06-25 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
| 68071-5173-4 | 2023-01-30 | C162847 | 48780-1 | f386c64a-31df-0266-e053-dadaa90a7c1a | Codeine-Guaifenesin Oral Solution |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-5173-4 | Codeine-Guaifenesin | 120 mL in 1 BOTTLE | SOLUTION | 120 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-5173 | CODEINE-GUAIFENESIN (CODEINE PHOSPHATE AND GUAIFENESIN) SOLUTION [NUCARE PHARMACEUTICALS,INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240627_9e691264-d48a-6b48-e053-2995a90a9352.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Medique at Home APAP Extra Strength | ACETAMINOPHEN 500 MG | Unifirst First Aid Corporation | b56b4110-fb8f-e5a0-e053-2995a90a0ad3 | 2025-09-08 | Warnings | M013 |
| Pain Reliever | ACETAMINOPHEN | P & L Development, LLC | 64c642b7-ef83-44b7-a014-6fa248dff3ba | 2025-09-08 | Warnings | M013 |
| Extra Strength Acetaminophen PM | ACETAMINOPHEN, DIPHENHYDRAMINE | BJWC (Berkley & Jensen / BJ's) | 2f473f1f-7cf3-2af5-e063-6394a90aaa17 | 2025-09-01 | Warnings | M013 |
| foster and thrive rapid release pain relief | ACETAMINOPHEN | Strategic Sourcing Services LLC | d2130173-b107-4ae6-a1f7-6db467da3820 | 2025-08-30 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | Precision Dose, Inc. | e1d4f562-433c-4344-9b77-1a7c731d1be5 | 2025-08-29 | Warnings | M013 |
| Aspirin Enteric Coated Low Dose | ASPIRIN | Walgreen Company | b11a4c4e-374c-403e-a757-5e9700f9f03b | 2025-08-27 | Warnings | M013 |
| pain relief | ACETAMINOPHEN | Safeway | 0e0a73f9-8c18-41fd-812e-8be20287e77a | 2025-08-26 | Warnings | M013 |
| Aspirin Low Dose Safety Coated | ASPIRIN | BJWC (Berkley & Jensen / BJ's) | 577035a5-88ab-431c-8598-7a19dd633fe9 | 2025-08-26 | Warnings | M013 |
| Topcare Pain Relief | ACETAMINOPHEN | Sixarp, LLC | 2e20be17-2b6c-1a07-e063-6394a90acdd3 | 2025-08-25 | Warnings | M013 |
| Low Dose Aspirin | ASPIRIN | BJWC (Berkley & Jensen / BJ's) | 2f32b096-d29a-c7c7-e063-6294a90a2bbe | 2025-08-22 | Warnings | M013 |
| Medique Medi Seltzer | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | Unifirst First Aid Corporation | 528da9d9-2a52-4c16-b7b2-61b3eee1abea | 2025-08-19 | Warnings | M013 |
| pain relief | ACETAMINOPHEN | Publix Super Markets Inc | 6b691dc1-09e4-46d3-b199-8917e42848a6 | 2025-08-19 | Warnings | M013 |
| Pain Relief Extra Strength | ACETAMINOPHEN | P & L Development, LLC | 59eb14a5-40b0-4331-beb5-7166e6cdf411 | 2025-08-18 | Warnings | M013 |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | caf5daea-409e-5dd2-e053-2995a90acb12 | 2025-08-18 | Warnings | M013 |
| Dr Simi Pain Relief 100 | ACETAMINOPHEN | Farmacias De Similares TX LLC | 3c42e48d-cdb2-eb74-e063-6394a90a2940 | 2025-08-13 | Warnings | M013 |
| Dr Simi Pain Relief | ACETAMINOPHEN | Farmacias De Similares TX LLC | 3c477d33-a8c2-d39f-e063-6294a90ac5f0 | 2025-08-13 | Warnings | M013 |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | CHAIN DRUG MARKETING ASSOCIATION INC | 4005f8dd-3050-4590-8703-6997444e8df3 | 2025-08-13 | Warnings | M013 |
| good sense headache relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | L. Perrigo Company | 4cae0580-7ee3-4f38-8d13-79c7d7615f8f | 2025-08-12 | Warnings | M013 |
| TYLENOL Extra Strength | ACETAMINOPHEN | Kenvue Brands LLC | 3bb7dc60-97b2-1291-e063-6294a90a26d9 | 2025-08-12 | Warnings | M013 |
| Dr Simi Pain Reliever PM | ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE | Farmacias De Similares TX LLC | 3c19ad99-6e0f-3116-e063-6394a90a914c | 2025-08-11 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 995868 | codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution | PSN | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution | SCD | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
| 995868 | codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution | SY | 9e691264-d48a-6b48-e053-2995a90a9352 | 3 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-5173-4 | 68071517304 | 120 mL in 1 BOTTLE (68071-5173-4) | 120 ml | 2020-02-12 | 0000-00-00 | No | No | Current |